VantAI Expands Strategic Collaboration with Blueprint Medicines to Advance Induced Proximity Drug Discovery
VantAI announced today that it has entered into a second expansion of its collaboration and license agreement with Blueprint Medicines.

Three complementary, phase shifting technologies…
…built to unlock the full potential of the proximity modulator modality